• Case-Based Roundtable
  • General Dermatology
  • Eczema
  • Chronic Hand Eczema
  • Chronic Spontaneous Urticaria
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Prurigo Nodularis
  • Buy-and-Bill

Article

Dermatology Times, Digital Edition, August 2010

Medical Missions 101 : Benefits far outweigh negatives when volunteering abroad, derms say Wonder Drug? : Ipilimumab dramatically improves survival in melanoma patients Special Report : Women & Skin

Newsletter

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.

Subscribe Now!
Related Videos
1 expert in this video
1 expert in this video
1 expert in this video
1 expert in this video
Related Content
Real-World Management Strategies for Alopecia Areata
May 7th 2025

Real-World Management Strategies for Alopecia Areata

Derm Dispatch: A Comprehensive Guide to Managing Eczema with Integrative Medicine
March 31st 2025

Derm Dispatch: A Comprehensive Guide to Managing Eczema with Integrative Medicine

Daily Derm Times: May 6, 2025
May 7th 2025

Daily Derm Times: May 6, 2025

The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
August 2nd 2024

The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients

Upadacitinib Shows Promise in Reducing Cardiovascular and Thrombotic Risks in Atopic Dermatitis Patients
May 6th 2025

Upadacitinib Shows Promise in Reducing Cardiovascular and Thrombotic Risks in Atopic Dermatitis Patients

Clinical Trial Validates Delgocitinib’s HRQoL Benefits
May 6th 2025

Clinical Trial Validates Delgocitinib’s HRQoL Benefits

© 2025 MJH Life Sciences

All rights reserved.